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Adverse short-term effects of air pollution on
health have been documented in recent years
(Katsouyanni et al. 2001; Pope et al. 1995;
Samet et al. 2000; Schwartz and Dockery
1992; Touloumi et al. 1996). The pollution
indicators were mainly ambient particles
(Katsouyanni et al. 1997; Pope and Dockery
1999; Samet et al. 2000), but gaseous pollu-
tants such as nitrogen dioxide, ozone, and
carbon monoxide have also been associated
with adverse effects on mortality and mor-
bidity (Samoli et al. 2006; Schwartz 1997;
Touloumi et al. 1996). The results from epi-
demiologic studies have led to revisions of
air quality guidelines and standards and
scheduled dates for regular revisions in the
future [European Commission (EC) 1999;
U.S. Environmental Protection Agency
(EPA) 1996; World Health Organization
(WHO) 2000].
CO is produced by incomplete combus-
tion of hydrocarbons. Its main source is vehi-
cle exhaust emissions; secondary important
sources are industry, heating, and fires. The
concentrations of CO as well as their fluctua-
tions are related to a large extent to the circu-
lation of cars. The introduction of catalytic
converters led to substantial reductions in
ambient CO levels (Viras et al. 1996). CO
concentrations are spatially heterogeneous
within a city, with higher concentrations on
busy roads and especially in street canyons.
In addition, CO concentrations in cars and
buses are much higher than ambient levels,
and can account for an important part of
exposure. Because of the spatial variability,
levels of CO measured at fixed monitoring
stations depend more on site characteristics
than do levels of other pollutants. Indoor air
can also be contaminated with high levels of
CO, because space heaters fueled with oil,
gas, or kerosene, gas stoves, and tobacco
smoking cause significant emissions of CO.
However, Georgoulis et al. (2002) have
shown that ambient CO levels are a signifi-
cant correlate and determinant of CO 48-hr
personal exposure, and in fact the only con-
sistent one between the five European cities
included in their analysis.
CO is one of the few ambient air pollu-
tants for which we know its biologically toxic
form, carboxyhemoglobin (COHb). Binding
of CO in the lungs with hemoglobin in the
blood forms COHb, which reduces the oxy-
gen-carrying capacity of the blood and impairs
the release of oxygen from hemoglobin to
extravascular tissues. These are the main
causes of tissue hypoxia produced by CO at
low exposure levels. The toxic effects of CO
become evident in organs and tissues with
high oxygen consumption such as the brain,
the heart, exercising skeletal muscle, and the
developing fetus. Severe hypoxia due to
acute CO poisoning may cause both
reversible, short-lasting neurologic deficits
and severe, often delayed neurologic damage
(WHO 2000). The mechanisms for effects
of low-level exposure are unclear, but likely
include reduced exercise capacity and exacer-
bation of cardiovascular symptoms in per-
sons with coronary heart or lung disease.
Reduced oxygen-carrying capacity of hemo-
globin predisposes toward cardiac ischemia
in persons with coronary artery disease. CO
and traffic related co-pollutants have also
been associated with alteration of the cardiac
autonomic regulation in population-based
studies (Liao et al. 2004) and in panel stud-
ies (Dales 2004; Riojas-Rodriges et al. 2006;
Timonen et al. 2006). Ambient daily CO
levels have been associated with increases in
daily mortality and hospital admissions for
cardiovascular diseases. The latter persists
even at very low CO levels, suggesting that
there is no threshold for the onset of these
effects. Whether the relation between daily
mortality and exposure to CO is causal or
whether CO might act as a proxy for com-
bustion particles is still an open question.
Ambient CO may act through other path-
ways than COHb formation, and at lower
levels those pathways may dominate the
adverse health effects (Schwela 2000).
One key limitation of previous studies
has been the use of data from a single or a
few locations. We address this limitation by
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presenting the results of analyses investigating
the short term effects of CO on mortality
from all and cardiovascular causes within the
APHEA-2 project (Air Pollution and Health:
A European Approach 2; Katsouyanni et al.
1996), which uses an extensive European
database of cities spanning across the
Continent. This database also allows a com-
prehensive and structured approach at the
second stage of the analysis, in which we
explore the role of effect modifiers in explain-
ing the heterogeneity of the relation of air
pollution and mortality across cities.
Materials and Methods
Data. The APHEA-2 project is a multicenter
study including 30 cities across Europe and
associated regions that studied short-term
health effects of air pollution. Data were col-
lected on daily counts of all-cause mortality,
excluding deaths from external causes
[International Classification of Diseases, 9th
Revision (ICD-9; WHO 1975) codes > 800]
and cardiovascular (CVD) mortality (ICD-9
codes 390–459). The data covered at least
3 consecutive years for each city within the
years 1990–1997. Details about the data
have been published elsewhere (Katsouyanni
et al. 2001).
Daily air pollution measurements were
provided by the monitoring networks estab-
lished in each town participating in the
APHEA-2 project (Katsouyanni et al.
1996). Nineteen cities provided data on
CO. A clear seasonal pattern was evident in
all cities, with higher levels during winter.
The mean correlation between the CO
measurements in the different monitoring
sites used ranged from 0.45 in Athens to
0.88 in Zurich. Time-series data on daily
temperature (°C, daily mean) were used to
control for the potential confounding effects
of weather.
There is evidence that the average of
2 days’ pollution correlates better with mor-
tality than a single day’s exposure (Schwartz
2000), and therefore we made an a priori
decision to study the average of lags 0 and 1
for CO.
Table 1 presents descriptive characteristics
of the individual city data sets. Together, they
comprise a population of more than 40 mil-
lion people. The Netherlands is considered
one urban area because of its relative small size
and dense population. The mean daily total
number of deaths ranged from 6 to 342. For
cardiovascular mortality, daily number of
deaths ranged from 6 to 143. The mean levels
of CO (maximum 8-hr average) ranged from
0.6 to 6.1 mg/m3. In the various cities, the
correlation between CO and particulate mat-
ter < 10 µm in aerodynamic diameter (PM10,
daily mean) ranged from 0.16 to 0.70,
between CO and black particles with an aero-
dynamic diameter < 4.5 µm—i.e., black
smoke (BS, daily mean)—from 0.67 to 0.82,
between CO and sulfur dioxide (daily mean)
from 0.35 to 0.82, between CO and NO2
(1-hr maximum) from 0.03 to 0.68, and
between CO and O3 (1-hr maximum) from
–0.25 to –0.65. There was substantial variabil-
ity among cities in the levels of all pollutants
and in mean daily temperature.
Methods. We used a hierarchic modeling
approach. First, we fit regression models in
each city separately to allow specific control
for seasonal effects, weather, and other
potential confounders. We used the results
of the individual city analysis, in turn, in a
second-stage analysis to provide overall esti-
mates and to investigate potential effect
modifiers.
Individual city analysis. We investigated
the CO–mortality associations for each city
using Poisson regression models allowing for
overdispersion. The city-specific model is of
the form: 
[1]
where E[Ytc] is the expected value of the
Poisson-distributed variable Ytc indicating the
daily mortality count on day t at city c with
Var(Ytc) = ϕE[Ytc], ϕ being the overdispersion
parameter, xitc is the value of the xi meteoro-
logic covariate on day t at city c, COtc is the air
pollution level on day t at city c. The smooth
functions s capture the nonlinear relationship
between the time-varying covariates and calen-
dar time and daily mortality. We used penal-
ized regression splines as smoothing functions,
as implemented by Wood (2000) in R. In this
setting, k is the number of basis functions. We
also included dummy variables for the day of
the week effect and holidays.
According to the APHEA-2 methodology
(Touloumi et al. 2004), the smooth function
of time serves as a proxy for any time-depen-
dent outcome predictors or confounders with
long-term trends and seasonal patterns not
explicitly included in the model. Hence we
removed long-term trends and seasonal pat-
terns from the data to guard against con-
founding by omitted variables. Weather
variables, which are associated with both mor-
tality and CO exposure, were also included.
Specifically, we included penalized splines of
temperature on the day of death and the day
before death in the models. We used natural
splines as basis functions for the penalized
regression splines. Based on our experiences
from previous analyses of the APHEA-2 data,
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Table 1. City descriptive data on the study period, population, exposure (CO), outcome (daily number of deaths), and potential effect modifiers.
Study period Population Total no. CO (mg/m3) No. of CO PM O3 % of population
Location (month/year) (× 1,000) of deaths CVD [mean (10th–90th)]a monitors (mean) (mean) SMR > 75 years of age Area
Athens 1/92–12/96 3,073 73 36 6.1 (3.5–9.2) 2 42.7 87.1 784 5.3 South
Barcelona 1/91–12/96 1,644 40 16 0.9 (0.4–1.7) 3 63.5 71.9 740 7.3 South
Basel 1/90–12/95 360 9 4 0.6 (0.4–1.1) 1 31.2 64.0 678 7.6 Northwest
Birmingham 1/92–12/96 2,300 61 28 1.0 (0.5–1.6) 1 24.5 55.7 895 6.5 Northwest
Budapest 1/92–12/95 1,931 80 40 5.1 (3.3–7.4) 8 41.0 83.8 1,136 6.6 Central-eastern
Geneva 1/90–12/95 317 6 2 1.5 (0.8–2.6) 4 39.7 67.3 608 6.4 Northwest
Helsinki 1/93–12/96 828 18 9 1.2 (0.7–1.9) 2 27.7 58.0 915 5.0 Northwest
Ljubljana 1/92–12/96 322 7 3 1.6 (0.6–3.0) 1 — 80.0 823 4.5 Central-eastern
London 1/92–12/96 6,905 169 71 1.4 (0.7–2.2) 3 28.8 44.9 851 6.5 Northwest
Lyon 1/93–12/97 416 9 3 3.8 (2.0–6.0) 4 41.8 66.6 579 8.5 Northwest
Milano 1/90–12/96 1,343 29 11 5.4 (2.9–8.7) 3 53.0 52.7 623 9.6 Northwest
Netherlands 1/90–9/95 15,400 342 143 0.6 (0.4–1.2) 5 40.1 69.8 757 5.5 Northwest
Prague 2/92–12/96 1,213 38 22 0.9 (0.5–1.5) 4 76.2 85.3 984 5.7 Central-eastern
Rome 1/92–12/96 2,775 56 23 4.1 (2.5–5.9) 5 58.7 47.5 585 6.2 South
Stockholm 1/90–12/96 1,126 30 15 0.8 (0.5–1.2) 2 15.6 65.0 666 11.0 Northwest
Teplice 1/90–12/97 625 18 8 0.7 (0.3–1.2) 5 47.9 55.5 1,173 3.5 Central-eastern
Torino 1/90–12/96 926 21 9 5.5 (2.8–9.1) 2 74.5 88.6 724 7.8 Northwest
Valencia 1/94–12/96 753 16 6 4.1 (2.4–5.9) 4 — 59.1 820 5.5 South
Zurich 1/90–12/95 540 13 6 1.2 (0.7–2.0) 3 31.3 66.8 666 7.2 Northwest
Abbreviations: —, no data; SMR, standardized mortality rate. 
aPercentiles.
we chose the number of basis functions (k) to
be 50 for each year of available data for the
time variable and 10 for the weather variables,
because we considered this number of basis
functions sufficient to catch very small fluctu-
ations in the analyzed time series. To control
the amount of smoothing separately in each
city, we then chose the smoothing parameters
that minimized the absolute value of the sum
of partial autocorrelation functions (PACFs)
of the residuals from lags 3 to 30. To account
for nonremovable serial correlation in the
residuals, we added autoregressive terms into
the model as appropriate (Brumback et al.
2000). In the special case of small cities (and
especially in cause-specific mortality with
small counts of daily events), we have noticed
in previous analyses that the above criterion
may lead to undercontrolling for season. In
those cases, we allowed more degrees of free-
dom (df) for time, provided that this imposed
only a minor burden on the sum of the resid-
ual PACFs. Hence, if such a case occurred, we
used at least 1 df/year.
To evaluate how sensitive our results were
to the choice of the degree of smoothing, we
also applied models using 3, 8, and 12 df/year
of available data for the time smooth.
We did not control for influenza epi-
demics because previously published results
(Braga and Zanobetti 2000; Touloumi et al.
2005) have shown that these do not bias the
association between air pollution and mor-
tality. It is unclear why the specific time
within a winter that an epidemic occurs in a
particular city should have much to do with
air pollution levels and hence confound the
relation under investigation. Nevertheless,
because previous studies have focused on
particles’ effects to further explore the poten-
tial confounding effects of influenza on CO,
we repeated the analysis for total mortality
adjusting for flu epidemics in the model
using 8 df/year for seasonality control. We
used the APHEA-2 method for influenza
control (Touloumi et al. 2004), including a
dummy variable taking the value of one
when the 7-day moving average of the respi-
ratory mortality was greater than the 90th
percentile of its city-specific distribution.
To investigate potential confounding
effects from other pollutants, we also applied
two pollutant models. In addition to CO, we
alternatively included PM10, BS, SO2, NO2,
or O3 (1 hr) in our model.
We investigated the exposure–response
relationship between CO and mortality
using threshold analysis. We selected a grid
of threshold values, ranging from 0.0 to
3.0 mg/m3 by increments of 0.5—i.e., 0.0,
0.5, 1.0, 1.5, 2.0, 2.5, 3.0 mg/m3. For each
threshold value h we fit the corresponding
city-specific model. In the threshold model, we
included the pollutant term in the model in
the form (pollutant-h)+, where x+ = x if x ≥ 0
and x+ = 0 if x < 0 and h is the threshold value.
We then computed the deviance of the fitted
model and summed the deviances for that
given threshold over all cities. We repeated for
all threshold values and finally plotted the
sums of the deviance versus the threshold val-
ues. Because deviance is a measure of goodness
of fit for the model, a possible threshold is the
one corresponding to the minimum sum of
the city-specific models’ deviance.
Second-stage analysis. After we analyzed
the average of lags 0 and 1 of CO in each
city, we assumed the city-specific effect esti-
mates bc to be normally distributed around
an overall estimate. To see whether some of
the variability in the estimates bc was
explained by city characteristics, we estimated
fixed-effects pooled regression coefficients by
weighted regression of the city-specific esti-
mates bc on potential effect modifiers (at city
level) with weights inversely proportional to
the variances of the estimates bc. If substantial
heterogeneity remained across city results
beyond the variation associated with the
effect modifiers, random-effects regression
models were applied. In these models, it was
assumed that city-specific estimates bc were a
sample of independent observations from a
normal distribution with the same mean and
variances equal to the between-cities variance
and the squared standard error of bc. The ran-
dom variance component was estimated by
iteratively reweighted least squares (Berkey
et al. 1995).
Potential effect modifiers used in the
analysis included variables describing a) the
air pollution level and mix in each city (i.e.,
mean levels of CO, PM10, BS, NO2, O3,
SO2, ratio of PM10:NO2); b) the exposure
(number of CO monitors, correlation
between monitors’ measurements); c) the
health status of the population (percentage of
cardiorespiratory deaths over total, crude
mortality rate, directly standardized mortality
rate using the age distribution of the
European population as standard, age struc-
ture described as percentage > 65, > 75, and
< 15 years of age); d) the geographic area
(northern, western, and central-eastern
European cities); and e) the climatic condi-
tions (mean temperature and relative humid-
ity levels). Unfortunately, there are very
sparse comparable socioeconomic status
(SES) indicators across the different countries
in Europe available at city level. In particular,
the only SES indicator available was the per-
cent of unemployed.
Results
Figure 1 shows the pooled percentage
increase in the daily number of deaths from
all causes and from cardiovascular causes
associated with 1-mg/m3 increase in CO
levels, for different degrees of seasonality
control. Because there was significant hetero-
geneity in the single-city results, pooled
estimates using random-effects models
are shown. Using the PACF criterion, a
1-mg/m3 increase in the 2-day mean of CO
levels, was associated with a 1.20% [95%
confidence interval (CI), 0.63–1.77%]
increase in total deaths and a 1.25% (95%
CI, 0.30–2.21%) increase in cardiovascular
deaths. The PACF criterion used on average
5 df/year for seasonality control when ana-
lyzing total mortality and 4 df/year for the
analysis of cardiovascular mortality. When
we adjusted for seasonality using 3 df/year
(i.e., fewer degrees of freedom compared
with the PACF), the estimated effects
increased by < 20% compared with the
model using the PACF criterion. When we
adjusted for seasonality using 8 and 12 df/year
(i.e., more degrees compared with the
PACF), the estimated effects decreased by
approximately 40%. As expected, increasing
the degrees of freedom for seasonality control
leads to a decrease of the magnitude of
the effect and consequently of the amount of
the observed heterogeneity. When we ana-
lyzed total mortality using 8 df/year for sea-
sonality control and also adjusting for
influenza epidemics, the pooled effect was
decreased only by 7% [associated estimate
0.61%; 95% CI, 0.22–1.02%)], supporting
the hypothesis of absence of confounding by
influenza epidemics.
Figure 2 presents the percentage increase
in the daily number of deaths from all causes
and cardiovascular causes and their 95% CI
associated with an increase of 1 mg/m3 in
the 2-day mean of CO levels in each city and
in all cities, as estimated from the models
using the PACF criterion for seasonality con-
trol. The statistically significant estimated
increases in total mortality per 1-mg/m3
increase in CO ranged from 0.98% in
Samoli et al.
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Figure 1. Estimated pooled percent increase in
total and cardiovascular mortality and its 95% con-
fidence intervals associated with an increase of
1 mg/m3 in the level of CO (average of lags 0–1),
using different methods for seasonality control—
i.e., with a fixed number of annual degrees of free-
dom and with variable numbers of annual degrees
of freedom according to the PACF. 
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Athens to 9.39% in Basel, whereas the corre-
sponding increases in cardiovascular mortal-
ity ranged from 0.76% in Athens to 15.69%
in Basel. Because Basel is a small city it has a
small weight on the pooled estimates; hence,
although it is an outlier it does not greatly
affect the pooled estimates. So when we
excluded Basel from the pooled estimates, a
1-mg/m3 increase in the 2-day mean of CO
levels, was associated with 1.11% increase
(95% CI, 0.69–1.53%) in total mortality
and 1.13% increase (95% CI, 0.50–1.77%)
in cardiovascular mortality.
Figure 3 presents the sum over all cities of
the city-specific deviances for different thresh-
old models versus the different threshold val-
ues explored in the analysis of CO and total
mortality. The overall deviance was mini-
mized for a potential threshold of 0.5 mg/m3;
however, the comparison between the
deviance of that threshold model and the lin-
ear no-threshold model yields a p-value > 0.9,
suggesting weak evidence for a threshold.
Table 2 presents results from two-pollu-
tant models, adjusting in turn for the con-
founding effects of BS, PM10, SO2, O3, and
NO2. CO associations with both total and
cardiovascular mortality were confounded by
BS and NO2 under both methods for season-
ality control, but remained marginally signifi-
cant. When adjusting for NO2, the estimated
increase in total mortality associated with an
increase of 1 mg/m3 in the 2-day mean of
CO-levels was reduced by 27% using the
PACF method and by 55% using 8 df/year,
and the corresponding increase in cardiovas-
cular mortality was reduced by 33% under
PACF and 47% under 8 df/year. When
adjusting for BS, the estimated increase in
total mortality associated with an increase of
1 mg/m3 in the 2-day mean of CO was
reduced by 36% under PACF and 32%
under 8 df/year, and the corresponding
increase in cardiovascular mortality was
reduced by 34% under PACF and 40%
under 8 df/year. The highest effects estimate
for CO was found when ozone was included
in the two-pollutant model.
Table 3 shows the resulting estimated
CO effect (that is, the increase in mortality
and its 95% CI per 1-mg/m3 increase in the
2-days mean of CO) for a city characterized
by a value in the effect modifier equal to the
25th (low) and 75th (high) percentile of the
distribution of this particular effect modifier.
Among the potential effect modifiers, we
present only those that explained > 10% of
the observed heterogeneity in the estimates
obtained both by the PACF criterion and
using 8 df/year for seasonality control.
When we investigated the source of het-
erogeneity in the association between CO
and total mortality, the most important
effect modifiers were the geographic area
(defined as western, southern, and central-
eastern European cities) and the age-stan-
dardized mortality rate. More specifically,
the effect of CO on total and cardiovascular
mortality was highest in western cities, fol-
lowed closely by the effect in southern
European cities, whereas there was only a
small and nonsignificant effect in eastern
cities. Higher effects of CO on mortality are
observed in cities with lower morality rates.
In addition, higher effects of CO on total
mortality are observed in cities with smaller
number of CO monitors and higher particle
levels, whereas the effect on cardiovascular
mortality is higher in cities with lower O3
levels and higher proportion of elderly.
Discussion
We used the most extensive European data-
base available today to investigate the effects
of CO on mortality from all causes and car-
diovascular causes. We found significant
associations of CO with total and cardiovas-
cular mortality. The slightly stronger effect
of CO on cardiovascular mortality is
expected, taking into consideration its bio-
logical mechanism and the fact that deaths
from cardiovascular causes account for about
45% of the total number of deaths in the
analyzed cities. The results of our threshold
analysis support the hypothesis of a linear
exposure–response relationship between CO
and mortality. The present findings comple-
ment those previously reported from
APHEA-1, which was the first part of the
APHEA project and included a smaller num-
ber of cites (i.e., for CO only 1, compared
with 19 cites included in the APHEA-2
analysis). As part of that analysis, Touloumi
et al. (1996) reported significant positive
associations between CO and daily total
mortality in Athens, Greece. In that first part
of the APHEA analysis, an increase per
1 mg/m3 in CO was associated with 1%
(95% CI, 0.5–1.5%) increase in total mortal-
ity, which is in agreement with the 1% (95%
CI, 0.7–1.3%) increase in Athens reported in
our results. Statistically significant associa-
tions between CO and total mortality have
previously been reported in Los Angeles,
California (Kinney and Ozkaynak 1991;
Shumway et al. 1988), the Netherlands
(Fischer et al. 2003), Russia (Katsnel’son
et al. 2000), and Canada (Burnett et al.
1998a, 1998b). In particular, Burnett et al.
(1998b) reported that the effects of the com-
plex air pollution mixture could be explained
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Figure 2. Percent increase in the daily number of deaths from all and cardiovascular causes and their 95%
CIs associated with an increase of 1 mg/m3 in the level of CO in each city and overall cities, as estimated
using the PACF criterion.
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Figure 3. Total deviance of different fixed threshold
models for the relationship between CO and total
mortality.
2087.5
2087.0
2086.5
2086.0
2085.5
2085.0
Su
m
 o
f d
ev
ia
nc
e 
of
 fi
tte
d 
th
re
sh
ol
d 
m
od
el
s
0.0
Threshold values (mg/m3)
0.5 1.0 1.5 2.0 2.5 3.0
almost completely by the levels of CO and
total suspended particulates.
Because a single pollutant could act as a
marker of a pollution mixture, the indepen-
dence of the adverse effect of CO on mortality
from those of other pollutants is unclear.
Hence, CO could be a marker of other pollu-
tants generated by vehicle exhausts such as
particles. We have tried to separate the inde-
pendent effects of pollutants using two-pollu-
tant models. There was evidence that CO
effects on total and cardiovascular mortality
were confounded by BS and NO2. Because
the pollutant-adjusted effects of CO remained
at least marginally statistically significant,
there appears to be a persistent effect of CO
additional to that of the other traffic-related
pollutants. The reduction of the CO effects
was in most cases higher when we allowed for
8 df/year for seasonality control, but it is
expected that the inclusion of additional pol-
lutants will have a greater effect on the smaller
effect estimates produced from increasing
degrees of freedom for seasonality. Because
CO had the highest correlations with BS, the
BS-adjusted estimates are limited by the
collinearity among pollutants generated by the
same source. On the other hand, the BS effect
on mortality (obtained under the same
methodology) is reduced by the same (in the
case of total mortality) or even greater (in the
case of cardiovascular mortality) amount after
the inclusion of CO, indicating the collinear-
ity of these pollutants but also the persistence
of the CO effect on cardiovascular mortality.
To a lesser degree, CO seems to have a con-
founding effect on the NO2 effects on mortal-
ity, especially under the PACF method. The
NO2-adjusted effect estimates of CO may
reflect, to a larger extent, the effects from
sources other than traffic. Further study focus-
ing on exposure to mixtures including NO2,
BS, and CO is needed to further our under-
standing of the etiologic mechanism through
which the pollutants affect mortality. The
highest effects estimate for CO was found
when O3 was included in the two-pollutant
model, due to the O3 effect on mortality
together with their negative correlation, which
is especially high in winter. This relation
between two harmful types of air pollutants is
also seen in the estimation of O3 effects
adjusting for CO (Gryparis et al. 2004).
We investigated several environmental
and social factors that might explain varia-
tion between cities in the effect estimates.
The effect of CO on total and cardiovascular
mortality was observed in western and south-
ern European cities, whereas there was essen-
tially no CO effect in eastern cities. This
geographic difference was also observed in
the effects of the other pollutants analyzed
within the APHEA project (Gryparis et al.
2004; Katsouyanni et al. 2001; Samoli et al.
2006). Hence any variables, such as the mor-
tality rate, that strongly differ between east-
ern and other regions are likely to appear as
significant explanatory factors of the hetero-
geneity in the effect estimates. Alternatively,
if the effect modifiers identified are indeed
true modifiers, their distribution across
Europe may result in these marked geo-
graphic differences. In agreement with this
possibility is the result that cities with larger
number of CO monitoring stations have
lower effect of CO on total mortality,
because three of the four eastern cities in our
analysis have a large number of CO monitor-
ing stations (above the 75th percentile of this
effect modifier’s distribution). Furthermore,
in cities with higher PM10 levels, the effect of
CO on total mortality is higher because traf-
fic is a predominant source of particles in
European cities with high PM concentra-
tions. For cardiovascular mortality, the effect
of CO is higher in cities with lower stan-
dardized mortality rate and higher propor-
tion of elderly. In fact, in the APHEA cities,
a large mortality rate was related to a smaller
proportion of elderly persons (Spearman r =
–0.33). An explanation may be that a low
standardized mortality rate and a high per-
centage of elderly implies a larger proportion
of individuals belonging to vulnerable groups
who are more susceptible to pollution effects
or, complimentarily, that in a population
with higher mortality there are more com-
peting risks. Finally, the result that in cities
with higher O3 levels the CO effect on car-
diovascular mortality is lower may reflect a
stronger effect of photochemical air pollu-
tion on mortality in the cities where such a
pollution mix is dominant. The situation is
also complicated by the fact that CO is
involved in atmospheric photochemistry.
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Table 2. Pooled estimates (95% CIs) for the percent increase in mortality associated with an increase of 1 mg/m3 in CO (average of lags 0 and 1), adjusting
alternatively for the other pollutants.
Total mortality CVD mortality
Other 8 df/year PACF 8 df/year PACF
pollutant Fixed effects Random effects Fixed effects Random effects Fixed effects Random effects Fixed effects Random effects
None 0.59 (0.41 to 0.78) 0.66 (0.27 to 1.05) 1.00 (0.83 to 1.18) 1.20 (0.63 to 1.77) 0.80 (0.53 to 1.07) 0.81 (0.36 to 1.26) 1.06 (0.80 to 1.32) 1.25 (0.30 to 2.21)
BS 0.35 (–0.03 to 0.72) 0.45 (–0.01 to 0.92) 0.67 (0.30 to 1.04) 0.77 (0.28 to 1.26) 0.49 (–0.04 to 1.02) 0.49 (–0.04 to 1.02) 0.83 (0.31 to 1.35) 0.83 (0.31 to 1.35)
PM10 0.48 (0.24 to 0.72) 0.58 (0.12 to 1.04) 0.78 (0.55 to 1.00) 1.09 (0.36 to 1.83) 0.73 (0.39 to 1.07) 0.73 (0.39 to 1.07) 0.95 (0.62 to 1.27) 1.13 (0.60 to 1.67)
SO2 0.44 (0.21 to 0.67) 0.46 (0.07 to 0.85) 0.68 (0.47 to 0.90) 0.75 (0.26 to 1.26) 0.72 (0.39 to 1.04) 0.68 (–0.03 to 1.40) 0.91 (0.59 to 1.22) 0.86 (0.06 to 1.66)
O3 (1 hr) 0.66 (0.46 to 0.86) 0.76 (0.45 to 1.06) 1.12 (0.93 to 1.31) 1.37 (0.81 to 1.95) 0.91 (0.62 to 1.20) 1.02 (0.58 to 1.46) 1.28 (1.01 to 1.56) 1.62 (0.72 to 2.52)
NO2 (1 hr) 0.27 (0.03 to 0.51) 0.30 (–0.11 to 0.71) 0.72 (0.50 to 0.95) 0.88 (0.22 to 1.55) 0.44 (0.10 to 0.79) 0.43 (–0.06 to 0.93) 0.68 (0.35 to 1.00) 0.84 (–0.03 to 1.71)
Table 3. Results of second-stage regression models, investigating the role of potential modifiersa of the estimated effectsb of CO on mortality.
Total mortality CVD mortality
8 df/year PACF 8 df/year PACF
Effect modifierc 25thd 75thd 25thd 75thd 25thd 75thd 25thd 75thd
No. of CO monitors 0.71 (0.48 to 0.94) 0.54 (0.34 to 0.74) 1.18 (0.96 to 1.39) 0.92 (0.73 to 1.11)
Mean PM10 levels 0.37 (0.08 to 0.66) 0.49 (0.28 to 0.69) 0.74 (0.46 to 1.02) 1.07 (0.87 to 1.27)
Mean O3 1.04 (0.67 to 1.41) 0.82 (0.55 to 1.10) 1.32 (0.96 to 1.68) 1.09 (0.83 to 1.35)
SMR 0.79 (0.55 to 1.03) 0.44 (0.22 to 0.66) 1.29 (1.06 to 1.52) 0.77 (0.56 to 0.98) 1.06 (0.71 to 1.42) 0.61 (0.30 to 0.93) 1.40 (1.06 to 1.75) 0.85 (0.55 to 1.14)
Population > 75 years 0.58 (0.25 to 0.92) 0.94 (0.64 to 1.24) 0.74 (0.41 to 1.06) 1.25 (0.96 to 1.54)
of age (%)
Geographic region
Western cities 0.75 (0.47 to 1.03) 1.15 (0.90 to 1.40) 1.06 (0.67 to 1.46) 1.38 (1.00 to 1.76)
Southern cities 0.61 (0.32 to 0.91) 1.08 (0.79 to 1.38) 0.70 (0.26 to 1.14) 0.90 (0.47 to 1.33)
Eastern cities 0.03 (–0.47 to 0.53) 0.27 (–0.20 to 0.74) 0.21 (–0.48 to 0.90) 0.48 (–0.14 to 1.11)
SMR, standardized mortality rate. 
aVariables characterizing each city; only statistically significant effect modifiers under both methods for seasonality control, reducing the heterogeneity by > 10% are presented. bEffect
estimates used from first-stage models are based on the PACF criterion and on 8 df/year for seasonality control. cThe effect modifiers were included alternatively in the model. dPercent
increase in mortality per 1-mg/m3 increase in the 2-day mean CO levels, estimated using fixed-effects model, for a city with levels of the corresponding effect modifier equal to the 25th
and the 75th percentiles of its distribution.
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In conclusion, we found adverse effects
of CO on mortality from all causes and car-
diovascular causes using the most extensive
European database. Although there was
indication of confounding by other vehicle-
derived pollutants, the unexplained short-
term effect of CO on mortality remained at
least marginally statistically significant. The
heterogeneity found in the effect estimates
among cities may be explained partly by fac-
tors characterizing the air pollution mix and
the health of the population.
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